Literature DB >> 18619649

Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.

Daniela Furlan1, Nora Sahnane, Ileana Carnevali, Roberta Cerutti, Francesco Bertoni, Ivo Kwee, Silvia Uccella, Valentina Bertolini, Anna Maria Chiaravalli, Carlo Capella.   

Abstract

The aim of the study was to identify the impact on prognosis of hypoxia-inducible factor-1 genetic program in colorectal carcinomas and to develop an experimental procedure that would allow a reliable quantitative gene expression analysis in formalin-fixed and paraffin-embedded tissue. The expression of hypoxia-inducible factor-1alpha and 13 hypoxia-inducible factor-1 target genes (AMF, CAIX, VEGF, VEGFR1, VEGFR2, HGF, MET, TGFalpha, EGFR, IGF2, MMP2, PLAUR, NIX) was quantified by real-time polymerase chain reaction in 18 colorectal, poorly differentiated neuroendocrine carcinomas and in 60 invasive colorectal carcinomas. Moreover, hypoxia-inducible factor-1alpha protein expression was evaluated by immunohistochemistry. High levels of hypoxia-inducible factor-1alpha were positively associated with poorly differentiated neuroendocrine carcinoma histology (P < .005), poor differentiation (P < .025), presence of necrosis, and presence of microsatellite instability (P < .05). AMF, TGFalpha, IGF2, NIX, VEGF, and VEGFR2 transcripts were significantly higher in the very aggressive poorly differentiated neuroendocrine carcinomas than in exocrine colorectal carcinomas and TGFalpha expression was significantly associated with presence of lymph nodal metastases (P < .05). High levels of TGFalpha and NIX were significantly associated with decreased overall survival (P < .001; P < .01). The multivariate analysis showed that advanced stage, presence of lymph node metastases, and high TGFalpha expression had an independent effect on survival (P < .006; P < .01; P < .0006). Our study suggests an up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas. hypoxia-inducible factor-1alpha overexpression alone, has no impact on the prognosis of colorectal carcinomas likely because the consequences of hypoxia-inducible factor-1alpha expression/stabilization strongly depend on the genetic background of the transformed cells. Mechanisms leading to increased synthesis of hypoxia-inducible factor-1alpha mRNA via autocrine growth factor loops may play a crucial role in invasive growth in this site.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619649     DOI: 10.1016/j.humpath.2008.02.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.

Authors:  Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Natsumi Irahara; Andrew T Chan; Jeffrey A Meyerhardt; Daniel C Chung; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

2.  Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer.

Authors:  Anna Novell; Montserrat Martínez-Alonso; Moises Mira; Jordi Tarragona; Antonieta Salud; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2014-04-08       Impact factor: 4.064

3.  Localization of carboxyl ester lipase in human pituitary gland and pituitary adenomas.

Authors:  Stefano La Rosa; Davide Vigetti; Claudia Placidi; Giovanna Finzi; Silvia Uccella; Moira Clerici; Barbara Bartolini; Ileana Carnevali; Marco Losa; Carlo Capella
Journal:  J Histochem Cytochem       Date:  2010-06-21       Impact factor: 2.479

4.  Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma.

Authors:  Mehran Gholamin; Omeed Moaven; Bahram Memar; Moein Farshchian; Hossein Naseh; Reza Malekzadeh; Masoud Sotoudeh; Mohammad Taghi Rajabi-Mashhadi; Mohammad Naser Forghani; Farid Farrokhi; Mohammad Reza Abbaszadegan
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

5.  Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer.

Authors:  Chan-Zhen Liu; Li Zhang; Xiao-Hong Chang; Ye-Xia Cheng; Hong-Yan Cheng; Xue Ye; Tian-Yun Fu; Jun Chen; Heng Cui
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

6.  Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth.

Authors:  Adam J Krieg; Erinn B Rankin; Denise Chan; Olga Razorenova; Sully Fernandez; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

7.  Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.

Authors:  David J Stewart; Maria I Nunez; Carmen Behrens; Diane Liu; Yan Heather Lin; J Jack Lee; Jack Roth; John Heymach; Stephen G Swisher; Waun Ki Hong; Ignacio Ivan Wistuba
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

8.  Tumor hypoxia as a driving force in genetic instability.

Authors:  Kaisa R Luoto; Ramya Kumareswaran; Robert G Bristow
Journal:  Genome Integr       Date:  2013-10-24

9.  Adenomatous polyposis coli and hypoxia-inducible factor-1{alpha} have an antagonistic connection.

Authors:  Ian P Newton; Niall S Kenneth; Paul L Appleton; Inke Näthke; Sonia Rocha
Journal:  Mol Biol Cell       Date:  2010-09-15       Impact factor: 4.138

10.  Advances in glucose metabolism research in colorectal cancer.

Authors:  Sitian Fang; Xiao Fang
Journal:  Biomed Rep       Date:  2016-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.